Caldwell Sutter Capital, Inc. Vaxart, Inc. Transaction History
Caldwell Sutter Capital, Inc.
- $210 Billion
- Q1 2025
A detailed history of Caldwell Sutter Capital, Inc. transactions in Vaxart, Inc. stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 2,000 shares of VXRT stock, worth $680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$680% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VXRT
# of Institutions
104Shares Held
35.8MCall Options Held
83.1KPut Options Held
120K-
Sio Capital Management, LLC New York, NY11.5MShares$3.92 Million2.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$3.43 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.99MShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.6MShares$884,3870.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$603,2770.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $43M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...